Deficiency of activating Fcγ-receptors reduces hepatic clearance and deposition of IC and increases CIC levels in mercury-induced autoimmunity

PLoS ONE

Volumn 5, Issue 10, 2010, Pages

  Martinsson, Klara ^a,b   Skogh, Thomas ^a   Mousavi, Seyed ^c   Berg, Trond ^d   Jönsson, Jan Ingvar ^a   Hultman, Per ^a  

^a LINKÖPING UNIVERSITY   (Sweden)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

^d UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

FC RECEPTOR; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; IMMUNOGLOBULIN G2B; MERCURY;

ANIMAL CELL; ANIMAL TISSUE; ANTIBODY TITER; ANTIGEN ANTIBODY COMPLEX; ARTICLE; AUTOIMMUNE DISEASE; BAGG ALBINO MOUSE; CONTROLLED STUDY; FEMALE; IMMUNE RESPONSE; LIVER; LIVER CLEARANCE; LIVER METABOLISM; MOUSE; NONHUMAN; SIGNAL TRANSDUCTION; SPLEEN CELL; ANIMAL; AUTOIMMUNITY; DRUG EFFECT; GENETICS; METABOLISM; MOUSE MUTANT;

MUS;

ANIMALS; AUTOIMMUNITY; LIVER; MERCURY; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; RECEPTORS, IGG;

EID: 78149484318     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0013413     Document Type: Article

References (52)

1. Nangaku M, Couser WG (2005) Mechanisms of immune-deposit formation and the mediation of immune renal injury. Clinical and experimental nephrology 9: 183-191.
2. Heyman B (2003) Feedback regulation by IgG antibodies. Immunology letters 88: 157-161.
3. Ravetch J. In vivo veritas: the surprising roles of Fc receptors in immunity. Nature immunology 11: 183-185.
4. Bogers WM, Stad RK, Janssen DJ, van Rooijen N, van Es LA, et al. (1991) Kupffer cell depletion in vivo results in preferential elimination of IgG aggregates and immune complexes via specific Fc receptors on rat liver endothelial cells. Clinical and experimental immunology 86: 328-333.
5. Johansson AG, Lovdal T, Magnusson KE, Berg T, Skogh T (1996) Liver cell uptake and degradation of soluble immunoglobulin G immune complexes in vivo and in vitro in rats. Hepatology (Baltimore, Md 24: 169-175.
6. Kosugi I, Muro H, Shirasawa H, Ito I (1992) Endocytosis of soluble IgG immune complex and its transport to lysosomes in hepatic sinusoidal endothelial cells. Journal of hepatology 16: 106-114.
7. Lovdal T, Andersen E, Brech A, Berg T (2000) Fc receptor mediated endocytosis of small soluble immunoglobulin G immune complexes in Kupffer and endothelial cells from rat liver. Journal of cell science 113(Pt 18): 3255-3266.
8. Mousavi SA, Sporstol M, Fladeby C, Kjeken R, Barois N, et al. (2007) Receptormediated endocytosis of immune complexes in rat liver sinusoidal endothelial cells is mediated by FcgammaRIIb2. Hepatology (Baltimore, Md 46: 871-884.
9. Skogh T, Blomhoff R, Eskild W, Berg T (1985) Hepatic uptake of circulating IgG immune complexes. Immunology 55: 585-594.
10. Skogh T, Stendahl O (1983) Complement-mediated delay in immune complex clearance from the blood owing to reduced deposition outside the reticuloendothelial system. Immunology 49: 53-59.
11. Izui S, McConahey PJ, Theofilopoulos AN, Dixon FJ (1979) Association of circulating retroviral gp70-anti-gp70 immune complexes with murine systemic lupus erythematosus. The Journal of experimental medicine 149: 1099-1116.
12. Hultman P, Skogh T, Enestrom S (1989) Circulating and tissue immune complexes in mercury-treated mice. Journal of clinical & laboratory immunology 29: 175-183.
13. Sasaki T, Muryoi T, Hatakeyama A, Suzuki M, Sato H, et al. (1991) Circulating anti-DNA immune complexes in active lupus nephritis. The American journal of medicine 91: 355-362.
14. Kotnik V, Premzl A, Skoberne M, Malovrh T, Kveder R, et al. (2003) Demonstration of apoptosis-associated cleavage products of DNA, complement activation products SC5b-9 and C3d/dg, and immune complexes CIC-C3d, CIC-IgA, and CIC-IgG in the urine of patients with membranous glomerulonephritis. Croatian medical journal 44: 707-711.
15. Zabaleta-Lanz M, Vargas-Arenas RE, Tapanes F, Daboin I, Atahualpa Pinto J, et al. (2003) Silent nephritis in systemic lupus erythematosus. Lupus 12: 26-30.
16. Zabaleta-Lanz ME, Munoz LE, Tapanes FJ, Vargas-Arenas RE, Daboin I, et al. (2006) Further description of early clinically silent lupus nephritis. Lupus 15: 845-851.
17. Kain R, Exner M, Brandes R, Ziebermayr R, Cunningham D, et al. (2008) Molecular mimicry in pauci-immune focal necrotizing glomerulonephritis. Nature medicine 14: 1088-1096.
18. Oates JC, Gilkeson GS (2002) Mediators of injury in lupus nephritis. Current opinion in rheumatology 14: 498-503.
19. Davies KA, Robson MG, Peters AM, Norsworthy P, Nash JT, et al. (2002) Defective Fc-dependent processing of immune complexes in patients with systemic lupus erythematosus. Arthritis and rheumatism 46: 1028-1038.
20. Nimmerjahn F, Ravetch JV (2008) Fcgamma receptors as regulators of immune responses. Nature reviews 8: 34-47.
21. Takai T, Li M, Sylvestre D, Clynes R, Ravetch JV (1994) FcR gamma chain deletion results in pleiotrophic effector cell defects. Cell 76: 519-529.
22. Hazenbos WL, Heijnen IA, Meyer D, Hofhuis FM, Renardel de Lavalette CR, et al. (1998) Murine IgG1 complexes trigger immune effector functions predominantly via Fc gamma RIII (CD16). J Immunol 161: 3026-3032.
23. Clynes R, Calvani N, Croker BP, Richards HB (2005) Modulation of the immune response in pristane-induced lupus by expression of activation and inhibitory Fc receptors. Clinical and experimental immunology 141: 230-237.
24. Bolland S, Ravetch JV (2000) Spontaneous autoimmune disease in Fc(gamma) RIIB-deficient mice results from strain-specific epistasis. Immunity 13: 277-285.
25. Kleinau S (2003) The impact of Fc receptors on the development of autoimmune diseases. Current pharmaceutical design 9: 1861-1870.
26. Kleinau S, Martinsson P, Heyman B (2000) Induction and suppression of collagen-induced arthritis is dependent on distinct fcgamma receptors. The Journal of experimental medicine 191: 1611-1616.
27. Martinsson K, Hultman P (2006) The role of Fc-receptors in murine mercuryinduced systemic autoimmunity. Clinical and experimental immunology 144: 309-318.
28. Martinsson K, Carlsson L, Kleinau S, Hultman P (2008) The effect of activating and inhibiting Fc-receptors on murine mercury-induced autoimmunity. Journal of autoimmunity 31: 22-29.
29. Havarinasab S, Hultman P (2005) Organic mercury compounds and autoimmunity. Autoimmunity reviews 4: 270-275.
30. Ahmed SS, Muro H, Nishimura M, Kosugi I, Tsutsi Y, et al. (1995) Fc receptors in liver sinusoidal endothelial cells in NZB/W F1 lupus mice: a histological analysis using soluble immunoglobulin G-immune complexes and a monoclonal antibody (2.4G2). Hepatology (Baltimore, Md 22: 316-324.
31. Kavai M, Szegedi G (2007) Immune complex clearance by monocytes and macrophages in systemic lupus erythematosus. Autoimmunity reviews 6: 497-502.
32. Willcocks LC, Lyons PA, Clatworthy MR, Robinson JI, Yang W, et al. (2008) Copy number of FCGR3B, which is associated with systemic lupus erythematosus, correlates with protein expression and immune complex uptake. The Journal of experimental medicine 205: 1573-1582.
33. Fenton KA, Tommeras B, Marion TN, Rekvig OP. Pure anti-dsDNA mAbs need chromatin structures to promote glomerular mesangial deposits in BALB/c mice. Autoimmunity 43: 179-188.
34. Fismen S, Hedberg A, Fenton KA, Jacobsen S, Krarup E, et al. (2009) Circulating chromatin-anti-chromatin antibody complexes bind with high affinity to dermo-epidermal structures in murine and human lupus nephritis. Lupus 18: 597-607.
35. Mjelle JE, Rekvig OP, Fenton KA (2007) Nucleosomes possess a high affinity for glomerular laminin and collagen IV and bind nephritogenic antibodies in murine lupus-like nephritis. Annals of the rheumatic diseases 66: 1661-1668.
36. Hultman P, Enestrom S, Pollard KM, Tan EM (1989) Anti-fibrillarin autoantibodies in mercury-treated mice. Clinical and experimental immunology 78: 470-477.
37. Hultman P, Enestrom S (1988) Mercury induced antinuclear antibodies in mice: characterization and correlation with renal immune complex deposits. Clinical and experimental immunology 71: 269-274.
38. Hultman P, Ganowiak K, Turley SJ, Pollard KM (1995) Genetic susceptibility to silver-induced anti-fibrillarin autoantibodies in mice. Clinical immunology and immunopathology 77: 291-297.
39. Hultman P, Johansson U, Turley SJ, Lindh U, Enestrom S, et al. (1994) Adverse immunological effects and autoimmunity induced by dental amalgam and alloy in mice. Faseb J 8: 1183-1190.
40. Hultman P, Bell LJ, Enestrom S, Pollard KM (1992) Murine susceptibility to mercury. I. Autoantibody profiles and systemic immune deposits in inbred, congenic, and intra-H-2 recombinant strains. Clinical immunology and immunopathology 65: 98-109.
41. Bergtold A, Gavhane A, D'Agati V, Madaio M, Clynes R (2006) FcR-bearing myeloid cells are responsible for triggering murine lupus nephritis. J Immunol 177: 7287-7295.
42. Tuzun E, Saini SS, Yang H, Alagappan D, Higgs S, et al. (2006) Genetic evidence for the involvement of Fcgamma receptor III in experimental autoimmune myasthenia gravis pathogenesis. Journal of neuroimmunology 174: 157-167.
43. Berger SP, Daha MR (2007) Complement in glomerular injury. Seminars in immunopathology 29: 375-384.
44. Stokol T, O'Donnell P, Xiao L, Knight S, Stavrakis G, et al. (2004) C1q governs deposition of circulating immune complexes and leukocyte Fcgamma receptors mediate subsequent neutrophil recruitment. The Journal of experimental medicine 200: 835-846.
45. Baudino L, Azeredo da Silveira S, Nakata M, Izui S (2006) Molecular and cellular basis for pathogenicity of autoantibodies: lessons from murine monoclonal autoantibodies. Springer seminars in immunopathology 28: 175-184.
46. Enestrom S, Hultman P (1984) Immune-mediated glomerulonephritis induced by mercuric chloride in mice. Experientia 40: 1234-1240.
47. Weening JJ, D'Agati VD, Schwartz MM, Seshan SV, Alpers CE, et al. (2004) The classification of glomerulonephritis in systemic lupus erythematosus revisited. Kidney international 65: 521-530.
48. Havarinasab S, Hultman P (2006) Alteration of the spontaneous systemic autoimmune disease in (NZB x NZW)F1 mice by treatment with thimerosal (ethyl mercury). Toxicology and applied pharmacology 214: 43-54.
49. Allhorn M, Collin M (2009) Sugar-free antibodies-the bacterial solution to autoimmunity? Annals of the New York Academy of Sciences 1173: 664-669.
50. Chia D, Barnett EV, Yamagata J, Knutson D, Restivo C, et al. (1979) Quantitation and characterization of soluble immune complexes precipitated from sera by polyethylene glycol (PEG). Clinical and experimental immunology 37: 399-407.
51. Skogh T, Stendahl O, Sundqvist T, Edebo L (1983) Physicochemical properties and blood clearance of human serum albumin conjugated to different extents with dinitrophenyl groups. International archives of allergy and applied immunology 70: 238-244.
52. Pittman RC, Carew TE, Glass CK, Green SR, Taylor CA, Jr., et al. (1983) A radioiodinated, intracellularly trapped ligand for determining the sites of plasma protein degradation in vivo. The Biochemical journal 212: 791-800.